Medical Properties Trust (MPT) Q3 2025 earnings summary

Executive summary

• Tenants across all asset types delivered strong operational and financial results, with general acute care operators seeing over $200 million EBITDARM increase year-over-year and post-acute operators up $50 million versus the same quarter last year.

• Net loss for Q3 2025 was $77.7 million ($0.13 per share), a significant improvement from a $801.2 million loss in Q3 2024, mainly due to lower impairment charges and fair value adjustments.

• Revenues increased 5% year-over-year to $237.5 million, driven by retenanting, CPI-based rent escalations, and new development completions.

• Strategic updates include successful re-leasing of Prospect's California facilities, asset sales in Phoenix/Arizona, and a new $150 million share repurchase program.

• International portfolio, comprising about 50% of assets, maintained coverage ratios above 2x, with notable operational and technological advancements in the UK, Germany, Switzerland, and Spain.

Financial highlights

• Reported normalized FFO/NFFO of $0.13 per share for Q3 2025; would have been $0.01 higher excluding timing of HSA rent payment.

• Net impairments of approximately $82 million, mainly related to Prospect Medical Group and certain Pennsylvania and Rhode Island assets.

• Total revenues for Q3 2025 were $237.5 million, up from $225.8 million in Q3 2024.

• Interest expense increased to $132.4 million in Q3 2025, reflecting higher rates from refinancing.

• Earnings from equity interest increased due to German tax policy changes and upward real estate revaluations in the CommonSpirit JV.

Outlook and guidance

• Confident in generating over $1 billion in annualized cash rent by year-end 2026, excluding any rent from California Prospect properties.

• Management expects rent and interest receipts to increase in the next twelve months due to contractual escalations and ramp-up from new tenants.

• Liquidity of $1.1 billion as of November 4, 2025, is expected to cover short-term requirements; only €500 million of unsecured notes due in the next year.

• Share repurchase program to begin immediately, funded by asset sales and available resources, not by incremental borrowing.

• No material new real estate investments are expected in the near term; focus remains on retenanting, asset sales, and cost management.